Brief Report: HIV Risk Perception and Pre-Exposure Prophylaxis Uptake Among Pregnant Women Offered Pre-Exposure Prophylaxis During Antenatal Care in Kenya.

IF 2.2 3区 医学 Q3 IMMUNOLOGY
Mary M Marwa, Anna Larsen, Felix Abuna, Julia Dettinger, Ben Odhiambo, Salphine Watoyi, Pascal Omondi, Nancy Ngumbau, Laurén Gómez, Grace John-Stewart, John Kinuthia, Jillian Pintye
{"title":"Brief Report: HIV Risk Perception and Pre-Exposure Prophylaxis Uptake Among Pregnant Women Offered Pre-Exposure Prophylaxis During Antenatal Care in Kenya.","authors":"Mary M Marwa, Anna Larsen, Felix Abuna, Julia Dettinger, Ben Odhiambo, Salphine Watoyi, Pascal Omondi, Nancy Ngumbau, Laurén Gómez, Grace John-Stewart, John Kinuthia, Jillian Pintye","doi":"10.1097/QAI.0000000000003641","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Self-perceived HIV risk influences pre-exposure prophylaxis (PrEP) use, although few data on risk perception are available among pregnant women. We evaluated HIV risk perception and PrEP uptake among pregnant women in Kenya.</p><p><strong>Methods: </strong>We used data from a randomized trial evaluating universal versus risk-based PrEP delivery models at 20 antenatal clinics in Kenya (NCT03070600). Pregnant women enrolled were offered PrEP at any gestational age. A validated risk score for predicting HIV acquisition among perinatal women defined high HIV risk. HIV risk perception was assessed by asking \"What is your gut feeling about how likely you are to get infected with HIV?\" without a specified timeframe and dichotomized as low (\"extremely/very unlikely\") versus high (\"extremely/somewhat likely/very likely\"). All women in the universal PrEP offer arm were included in the analysis.</p><p><strong>Results: </strong>Among 2250 pregnant women, the median age was 24 years (interquartile range 21-28), 81% were married, and 22% did not know their partner's HIV status. Overall, 27% of women had high HIV risk scores of whom 61% self-perceived high risk. Among women with high HIV risk scores (n = 617), 69% declined PrEP; those who self-perceived low risk were more likely to decline than those with high risk perception (82% vs. 60%, adjusted prevalence ratio = 1.35, 95% confidence interval: 1.17-1.55, P < 0.001). Declining PrEP was associated with late gestational age at PrEP offer and with monogamous marriage among women with high HIV risk scores ( P < 0.05).</p><p><strong>Conclusions: </strong>Declining PrEP was common among pregnant women with high HIV risk, especially those who self-perceived low HIV risk. Refining risk perception may encourage PrEP uptake.</p>","PeriodicalId":14588,"journal":{"name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":" ","pages":"116-122"},"PeriodicalIF":2.2000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12265992/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAIDS Journal of Acquired Immune Deficiency Syndromes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAI.0000000000003641","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Self-perceived HIV risk influences pre-exposure prophylaxis (PrEP) use, although few data on risk perception are available among pregnant women. We evaluated HIV risk perception and PrEP uptake among pregnant women in Kenya.

Methods: We used data from a randomized trial evaluating universal versus risk-based PrEP delivery models at 20 antenatal clinics in Kenya (NCT03070600). Pregnant women enrolled were offered PrEP at any gestational age. A validated risk score for predicting HIV acquisition among perinatal women defined high HIV risk. HIV risk perception was assessed by asking "What is your gut feeling about how likely you are to get infected with HIV?" without a specified timeframe and dichotomized as low ("extremely/very unlikely") versus high ("extremely/somewhat likely/very likely"). All women in the universal PrEP offer arm were included in the analysis.

Results: Among 2250 pregnant women, the median age was 24 years (interquartile range 21-28), 81% were married, and 22% did not know their partner's HIV status. Overall, 27% of women had high HIV risk scores of whom 61% self-perceived high risk. Among women with high HIV risk scores (n = 617), 69% declined PrEP; those who self-perceived low risk were more likely to decline than those with high risk perception (82% vs. 60%, adjusted prevalence ratio = 1.35, 95% confidence interval: 1.17-1.55, P < 0.001). Declining PrEP was associated with late gestational age at PrEP offer and with monogamous marriage among women with high HIV risk scores ( P < 0.05).

Conclusions: Declining PrEP was common among pregnant women with high HIV risk, especially those who self-perceived low HIV risk. Refining risk perception may encourage PrEP uptake.

在肯尼亚产前保健期间,孕妇对艾滋病毒风险的认知和PrEP的接受情况。
背景:自我认知的艾滋病毒风险影响PrEP的使用,尽管很少有数据的风险认知孕妇。我们评估了肯尼亚孕妇对艾滋病毒风险的认知和PrEP的接受情况。方法:我们利用了一项随机试验的数据,该试验评估了肯尼亚20家产前诊所的普遍与基于风险的PrEP分娩模式(NCT03070600)。参与研究的孕妇在任何胎龄都被提供PrEP。预测围产期妇女感染艾滋病毒的有效风险评分定义了高艾滋病毒风险。评估艾滋病毒风险的方式是询问“你对自己感染艾滋病毒的可能性的直觉是什么?”,没有特定的时间框架,并分为低(“极有可能/非常不可能”)和高(“极有可能/有点可能/非常有可能”)。所有接受普遍PrEP治疗的妇女都被纳入分析。结果:2250名孕妇中位年龄为24岁(IQR 21-28), 81%已婚,22%不知道其伴侣的艾滋病毒状况。总体而言,27%的妇女有较高的艾滋病毒风险得分,其中61%的妇女自我认为有高风险。在艾滋病毒风险评分较高的妇女中(n=617), 69%的人减少了PrEP;自认为低危的孕妇比自认为高危的孕妇更容易出现PrEP下降(82% vs. 60%, aPR=1.35, 95% CI 1.17-1.55, p)结论:PrEP下降在HIV高危孕妇中普遍存在,尤其是自认为低危的孕妇。改善风险认知可能会鼓励PrEP的使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.80
自引率
5.60%
发文量
490
审稿时长
3-6 weeks
期刊介绍: JAIDS: Journal of Acquired Immune Deficiency Syndromes​ seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide. JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信